OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
2.760
+0.440 (18.97%)
At close: Jan 9, 2026, 4:00 PM EST
2.800
+0.040 (1.45%)
After-hours: Jan 9, 2026, 7:58 PM EST
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $103.81 million as of January 9, 2026. Its market cap has increased by 189.42% in one year.
Market Cap
103.81M
Enterprise Value
102.24M
1-Year Change
189.42%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since the IPO on September 4, 2013, OKYO Pharma's market cap has decreased from $141.20M to $103.81M, a decrease of -26.48%. That is a compound annual growth rate of -2.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 103.81M | 33.33% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -48.55% |
| Dec 10, 2021 | 82.51M | 4.85% |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |